When you hear the word epilepsy, what comes to mind? For many, it rsquo;s a vague image of someone having a seizure ndash; ...

Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...

Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some ...

Neurostimulation devices use electrical impulses to modulate nervous system activity, helping treat chronic pain, neurological disorders, and mental health conditions. ” - Exactitude Consultancy ...

UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.

Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, ...

Sleep Apnea Implants MarketThe global sleep apnea implants market is projected to grow at a CAGR of 3.8% from 2024 to 2035, ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare ...

This milestone follows the successful IRB approval, pilot testing and evaluation of Nexalin’s Halo technology at UCSD. The study will evaluate Nexalin’s proprietary Deep Intracranial Frequency ...

Introduction to the Nerve Repair MarketThe nerve repair market is a rapidly growing sector within the healthcare and medical ...